In vivo blockade of human IL-2 receptor (IL-2R) induces expansion of CD56bright regulatory NK cells in patients with active uveitis.

被引：0
|
作者：
Li, ZQ
Lim, WK
Mahesh, SP
Nussenblatt, RB
机构：
[1] NEI, Immunol Lab, NIH, Bethesda, MD 20892 USA
[2] Singapore Natl Eye Ctr, Singapore, Singapore
来源：
CLINICAL IMMUNOLOGY | 2005年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S213 / S213
页数：1
相关论文
共 50 条
  • [1] Cutting edge:: In vivo blockade of human IL-2 receptor induces expansion of CD56bright regulatory NK cells in patients with active uveitis
    Li, ZQ
    Lim, WK
    Mahesh, SP
    Liu, BY
    Nussenblatt, RB
    JOURNAL OF IMMUNOLOGY, 2005, 174 (09): : 5187 - 5191
  • [2] Cutting edge:: in vivo blockade of human IL-2 receptor induces expansion of CD56bright regulatory NK cells in patients with active uveitis (vol 174, pg 5187, 2005)
    Li, Z
    Lim, WK
    Mahesh, SP
    Liu, B
    Nussenblatt, RB
    JOURNAL OF IMMUNOLOGY, 2005, 175 (05): : 3447 - 3447
  • [3] An IL-2 Paradox: Blocking CD25 on T Cells Induces IL-2-Driven Activation of CD56bright NK Cells
    Martin, Jayne F.
    Perry, Justin S. A.
    Jakhete, Neha R.
    Wang, Xiang
    Bielekova, Bibiana
    JOURNAL OF IMMUNOLOGY, 2010, 185 (02): : 1311 - 1320
  • [4] An IL-2 Paradox; Blocking CD25 on T Cells Induces IL-2-Driven Activation of CD56bright NK Cells
    Martin, Jayne F.
    Jakhete, Neha R.
    Wang, Xiang
    Bielekova, Bibiana
    NEUROLOGY, 2010, 74 (09) : A368 - A368
  • [5] IL-2 Induces Selective Activation of Helios-Positive Regulatory T Cells and CD56bright NK Cells in Vitro and in Patients with Chronic Gvhd Receiving Low-Dose IL-2 Therapy
    Hirakawa, Masahiro
    Matos, Tiago R.
    Koreth, John
    Forcade, Edouard
    Whangbo, Jennifer
    Murase, Kazuyuki
    Liu, Hongye
    Nikiforow, Sarah
    Ho, Vincent T.
    Cutler, Corey S.
    Armand, Philippe
    Alyea, Edwin P.
    Antin, Joseph H.
    Soiffer, Robert J.
    Ritz, Jerome
    BLOOD, 2015, 126 (23)
  • [6] IL-7 Enhances Survival of Human CD56bright NK Cells
    Michaud, Annie
    Dardari, R'Kia
    Charrier, Emily
    Cordeiro, Paulo
    Herblot, Sabine
    Duval, Michel
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (04) : 382 - 390
  • [7] Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis
    Bielekova, B
    Catalfamo, M
    Reichert-Scrivner, S
    Packer, A
    Cerna, M
    Waldmann, TA
    McFarland, H
    Henkart, PA
    Martin, R
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (15) : 5941 - 5946
  • [8] Competitive inhibition of IL-2/IL-2R has a dual effect on HSC ex vivo expansion and IL-2R (CD25) content
    Uslu, Merve
    Albayrak, Esra
    Kocabas, Fatih
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 110
  • [9] Maintenance therapy with histamine plus IL-2 induces a striking expansion of two CD56bright NK cell subpopulations in patients with acute myeloid leukemia and supports their activation
    Cuapio, Angelica
    Post, Mirte
    Cerny-Reiterer, Sabine
    Gleixner, Karoline V.
    Stefanzl, Gabriele
    Basilio, Jose
    Herndlhofer, Susanne
    Sperr, Wolfgang R.
    Brons, Nicolaas H. C.
    Casanova, Emilio
    Zimmer, Jacques
    Valent, Peter
    Hofer, Erhard
    ONCOTARGET, 2016, 7 (29) : 46466 - 46481
  • [10] Low-dose IL-2 induces CD56bright NK regulation of T cells via NKp44 and NKp46
    McQuaid, S. L.
    Loughran, S. T.
    Power, P. A.
    Maguire, P.
    Szczygiel, A.
    Johnson, P. A.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2020, 200 (03): : 228 - 241
12345